The Affiliated Hospital of Xuzhou Medical University clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
| First posted | New trial filing | Phase | Status |
|---|---|---|---|
| 2026-11-19 | NCT07949656 Anisodine Hydrobromide for Acute Vertebrobasilar Artery Occlusion Undergoing Endovascular… | Phase 1 | Not Yet Recruiting |
Active trials by phase
| Early Phase 1 | 3 | |
| Phase 1 | 3 | |
| Phase 1/2 | 3 | |
| Phase 2 | 4 | |
| Phase 3 | 1 | |
| Phase 4 | 2 |
Not charted: 12 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 16
Non-Hodgkin Lymphoma (3) · Diabetes (2) · Heart Disease (2) · Liver Cancer (2) · Stroke (2) · Type 2 Diabetes (2) · Chronic Lymphocytic Leukemia (CLL) (1) · DLBCL (1) · Heart Failure (1) · Leukemia (1)
Get alerts when The Affiliated Hospital of Xuzhou Medical University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.